Recombinant Human HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Tetramer Protein
Beta LifeScience
SKU/CAT #: BLK-00978P-100UG

Human HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Tetramer on Tris-Bis PAGE under under Non reducing (N) condition. The purity is greater than 95%.
Recombinant Human HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Tetramer Protein
Beta LifeScience
SKU/CAT #: BLK-00978P-100UG
Collections: Fc receptors, Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human HPV16 E7(HLA-A*02:01) Tetramer Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus, tetramer is assembled by biotinylated monomer and streptavidin.It contains Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M) and YMLDLQPET peptide. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | P04439-1(HLA-A*02:01)&P61769(B2M)&YMLDLQPET peptide |
Target Symbol | HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Tetramer |
Synonyms | HPV16; E7; MHC; |
Species | Human |
Expression System | HEK293 |
Tag | C-His-Avi |
Expression Range | Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)and YMLDLQPET peptide |
Mol. Weight | The protein has a predicted MW of 258 kDa. Due to glycosylation, the protein migrates to 260-265 kDa under Non reducing (N) condition based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KDEL) to the HPV16 E7-specific affibody. |